Drug shortages homepage
Welcome to Drug Shortages Canada, the website for reporting drug shortages and discontinuations in Canada. The Food and Drug Regulations require drug sellers to report when they are not able to meet demand for a product or when they stop selling a product. Information about the website and the regulations can be found on the About & Resources Page.
A shortage means, in respect of a drug, a situation in which the manufacturer to whom a document was issued under subsection C.01.014.2(1) that sets out the drug identification number assigned for the drug is unable to meet the demand for the drug.
Below are the newest and most recently updated Shortage and Discontinuation reports.
Shortage Reports
| Brand name | Company Name | Status | Strength | Update | Date Updated | View Report |
|---|---|---|---|---|---|---|
| CEENU | BRISTOL-MYERS SQUIBB CANADA | Anticipated shortage | 40MG | Updated Report | 2021-01-27 | 130007 |
| KINEVAC | BRACCO IMAGING CANADA | Anticipated shortage | 5MCG | New Report | 2021-01-27 | 132553 |
| CHOLETEC | BRACCO IMAGING CANADA | Actual shortage | 45MG | Updated Report | 2021-01-27 | 122962 |
| XYLOCAINE 2% W EPINEPHRINE 1:200000 | ASPEN PHARMACARE CANADA INC. | Actual shortage | 20MG 5MCG | Updated Report | 2021-01-27 | 131563 |
| ELETRIPTAN | PRO DOC LIMITEE | Actual shortage | 40MG | Updated Report | 2021-01-27 | 121563 |
| RILUTEK | SANOFI-AVENTIS CANADA INC | Actual shortage | 50MG | Updated Report | 2021-01-27 | 98763 |
| APRESOLINE | STERIMAX INC | Actual shortage | 20MG | Updated Report | 2021-01-27 | 91935 |
| PMS-NIFEDIPINE ER | PHARMASCIENCE INC | Actual shortage | 30MG | Updated Report | 2021-01-27 | 93825 |
| PMS-NIFEDIPINE ER | PHARMASCIENCE INC | Actual shortage | 60MG | Updated Report | 2021-01-27 | 98823 |
| DEPO-PROVERA STERILE AQUEOUS SUSPENSION 150 MG/ML | PFIZER CANADA ULC | Anticipated shortage | 150MG | Updated Report | 2021-01-27 | 131489 |
Discontinuation Reports
| Brand name | Company Name | Status | Strength | Update | Date Updated | View Report |
|---|---|---|---|---|---|---|
| DDAVP RHINYLE | FERRING INC | To be discontinued | 0.1MG | New Report | 2021-01-26 | 132472 |
| APO-CELECOXIB | APOTEX INC | Discontinued | 200MG | Updated Report | 2021-01-21 | 60366 |
| IMURAN | ASPEN PHARMACARE CANADA INC. | To be discontinued | 50MG | Updated Report | 2021-01-21 | 128667 |
| INVIRASE | HOFFMANN-LA ROCHE LIMITED | Discontinued | 500MG | New Report | 2021-01-20 | 132101 |
| HUMATROPE | ELI LILLY CANADA INC | Discontinued | 1MG | Updated Report | 2021-01-18 | 106800 |
| LIVOSTIN SUS NAS 0.5MG/ML | JANSSEN INC | Discontinued | 0.05MG | Updated Report | 2021-01-13 | 117970 |
| ODAN-METHADONE | ODAN LABORATORIES LTD | Reversed | 10MG | New Report | 2020-12-31 | 126845 |
| VENTOLIN NEBULES P.F. - 5MG/2.5ML | GLAXOSMITHKLINE INC | To be discontinued | 5MG | New Report | 2020-12-23 | 130636 |
| VENTOLIN NEBULES P.F. - 2.5MG/2.5ML | GLAXOSMITHKLINE INC | To be discontinued | 2.5MG | New Report | 2020-12-23 | 130633 |
| FORTAZ | GLAXOSMITHKLINE INC | Discontinued | 2G | Updated Report | 2020-12-22 | 130597 |
| FORTAZ | GLAXOSMITHKLINE INC | Discontinued | 1G | Updated Report | 2020-12-22 | 130594 |
| FORTAZ | GLAXOSMITHKLINE INC | Discontinued | 6G | New Report | 2020-12-22 | 130600 |
| TRANSDERM-NITRO 0.4 | NOVARTIS PHARMACEUTICALS CANADA INC | Discontinued | 0.4MG | Updated Report | 2020-12-21 | 119964 |
| TRANSDERM-NITRO 0.2 | NOVARTIS PHARMACEUTICALS CANADA INC | Discontinued | 0.2MG | Updated Report | 2020-12-21 | 119960 |
| SELECTBAG ONE (AX275G) | BAXTER CORPORATION | Discontinued | 36.0G 220.0G 51.5G 29.8G 20.3G | Updated Report | 2020-12-18 | 125887 |
| NORPROLAC | FERRING INC | Discontinued | 0.075MG | Updated Report | 2020-12-11 | 129605 |
| AVANDIA | GLAXOSMITHKLINE INC | Discontinued | 4MG | Updated Report | 2020-12-11 | 113314 |
| ERWINASE | JAZZ PHARMACEUTICALS FRANCE SAS | To be discontinued | 10000UNIT | Updated Report | 2020-12-11 | 129623 |
| BAL IN OIL 3ML AMPULES/10 | TAYLOR PHARMACEUTICALS | Discontinued | 100MG | Updated Report | 2020-12-11 | 130010 |
| ABILIFY | OTSUKA PHARMACEUTICAL CO LTD | To be discontinued | 15MG | New Report | 2020-12-10 | 129994 |
